Newstral
Tesaro Inc
- MGlaxoSmithKline's credit rating revised to negative at Moody's after Tesaro buyout dealmarketwatch.com
- MTesaro's stock rockets after $5.1 billion buyout deal with GlaxoSmithKlinemarketwatch.com
- MTesaro shares plummet 9% after Q4 earnings, revenue missesmarketwatch.com
- MNeurocrine Biosciences’ new drug may cost patients more than $10,000 a month, twice as much as expectedmarketwatch.com
- Tesaro Receives Early FDA Approval for Ovarian Cancer Drug Zejulajdsupra.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.